Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group
Johnson, CC., Wilcosky, T., Kvale, P., Rosen, M., Stansell, J., Glassroth, J., Reichman, L., Wallace, J., Markowitz, N., Thompson, J., & Hopewell, P. (1997). Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group. American Journal of Epidemiology, 146(6), 470-475.
Malignancies, particularly Kaposi's sarcoma and non-Hodgkin's lymphoma (NHL), are associated with human immunodeficiency virus (HIV) infection. Cancer incidence among 1,073 asymptomatic HIV-infected individuals from the Pulmonary Complications of HIV Infection Study cohort, persons from six states followed from 1988 to 1994, was examined. Total cancer incidence was 3.99/100 person-years; for Kaposi's sarcoma, incidence was 2.64 cases/100 person-years, and for NHL, it was 1.18 cases/100 person-years. Total cancer (n = 156 cases) was higher among nonblacks than among blacks (rate ratio = 2.8, 95% confidence interval 1.3-6.1), with similar results for Kaposi's sarcoma and NHL. The rate of lung cancer (n = 5) among white, homosexual/bisexual males was 0.18 per 100 person-years, suggesting a high risk of lung cancer